USPTO Grants Oragenics Patent for Improved Replacement Therapy for Dental Caries

Oragenics scored a U.S. patent protection for the generation SMaRT Replacement Therapy for live biotherapeutic compositions and methods for preventing dental caries.

The USPTO issued the ’488 patent, “Replacement Therapy for Dental Caries,” which gives Oragenics a 17-year patent protection period for SMaRT.

The patent protects SMaRT compositions and delivery forms, including mouthwash, toothpaste, chewing gum, floss, chewable tablet, food and beverages.

“The SMaRT Replacement Therapy was designed to be a painless, one-time, five-minute topical treatment applied to the teeth that has the potential to offer lifelong protection against tooth decay,” said Jeffrey Hillman, co-inventor of SMaRT Technology and co-founder of Oragenics. — Anisa Jibrell